KISSEI Pharmaceutical Reports Strong Quarterly Growth

Kissei Pharmaceutical Co (JP:4547) has released an update.

KISSEI PHARMACEUTICAL CO., LTD. reported a solid financial performance for the first quarter ended June 30, 2024, with a 9.6% increase in net sales and a significant 32.2% rise in operating profit compared to the same period last year. The company also announced an optimistic full year forecast, expecting a 9.8% growth in net sales and a moderate 1.2% increase in profit attributable to owners. No changes have been made to the most recently announced forecast for dividends, which is set at 90 yen for the fiscal year ending March 31, 2025.

For further insights into JP:4547 stock, check out TipRanks’ Stock Analysis page.